METASTASES TO KIDNEY

This adverse event was reported 551 times

These drugs are most commonly taken by patients reporting METASTASES TO KIDNEY:

# Drug Count
0 CARBOPLATIN 33
1 EVEROLIMUS 33
2 BEVACIZUMAB 26
3 PALBOCICLIB 25
4 PAZOPANIB HYDROCHLORIDE 24
5 METFORMIN 22
6 METFORMIN ER 500 MG 22
7 METFORMIN ER 750 MG 22
8 PACLITAXEL 21
9 PACLITAXEL (AIBUMIN-BOUND) 21
See all common drugs associated with METASTASES TO KIDNEY

METASTASES TO KIDNEY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 JOINT SUPPORT 1 0.0500
1 FERRIC SUBSULFATE 1 0.0385
2 INTERLEUKIN-10 2 0.0056
3 SOMAPACITAN-BECO 1 0.0055
4 DEMECLOCYCLINE 1 0.0044
5 TERCONAZOLE 1 0.0012
6 BISACODYL 5MG 1 0.0011
7 BACILLUS CALMETTE-GUERIN 2 0.0011
8 TAFASITAMAB-CXIX 1 0.0011
9 SODIUM IODIDE I 123 1 0.0011
See all drugs enriched for association with METASTASES TO KIDNEY

METASTASES TO KIDNEY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 2 0.0011
1 Actinomycin [EPC] 1 0.0005
2 Ergot Derivative [EPC] 2 0.0004
3 Estrogen Receptor Antagonist [EPC] 15 0.0004
4 Provitamin D2 Compound [EPC] 11 0.0004
5 Glinide [EPC] 3 0.0003
6 Chloride Channel Activator [EPC] 3 0.0003
7 Aromatase Inhibitor [EPC] 34 0.0003
8 Somatostatin Analog [EPC] 2 0.0003
9 Sulfone [EPC] 3 0.0003
See all drug classes enriched for association with METASTASES TO KIDNEY